Cited 8 time in
Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yoo, Jung-Wan | - |
| dc.contributor.author | Kim, Jehun | - |
| dc.contributor.author | Song, Jin Woo | - |
| dc.date.accessioned | 2024-12-02T21:30:50Z | - |
| dc.date.available | 2024-12-02T21:30:50Z | - |
| dc.date.issued | 2022-05 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/71856 | - |
| dc.description.abstract | The revised definition of acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) was proposed in 2016, but changes in the incidence and impact on prognosis of the re-defined AE compared to those of the previous definition remain unclear. Clinical data of 445 patients with IPF (biopsy proven cases: 165) were retrospectively reviewed. The median follow-up period was 36.8 months and 17.5% (n = 78) experienced AE more than once. The 1- and 3-year incidence rates of AE were 6.7% and 16.6%, respectively, and idiopathic AE accounted for 82.1% of AE. Older age, lower diffusing capacity of the lung for carbon monoxide and 10% relative decline in forced vital capacity for 6 months were independently associated with AE. The in-hospital mortality rate following AE was 29.5%. In the multivariable analysis, AE was independently associated with poor prognosis in patients with IPF. Compared to the old definition, the revised definition relatively increased the incidence of AE by 20.4% and decreased the in-hospital mortality by 10.1%. Our results suggest that the revised definition affects approximately 20% increase in the incidences and 10% reduction in the in-hospital mortality of AE defined by the past definition. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Nature Publishing Group | - |
| dc.title | Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/s41598-022-12693-5 | - |
| dc.identifier.scopusid | 2-s2.0-85130728775 | - |
| dc.identifier.wosid | 000802776400015 | - |
| dc.identifier.bibliographicCitation | Scientific Reports, v.12, no.1 | - |
| dc.citation.title | Scientific Reports | - |
| dc.citation.volume | 12 | - |
| dc.citation.number | 1 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
| dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
| dc.subject.keywordPlus | RISK-FACTORS | - |
| dc.subject.keywordPlus | STANDARDIZATION | - |
| dc.subject.keywordPlus | DIAGNOSIS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
